Copaxone (Co-PAX-ohn, copolymer-1 or "cop-1") for multiple sclerosis (MS)

September 1996

Patients will be asking you about Copaxone (Co-PAX-ohn, copolymer-1 or "cop-1") for multiple sclerosis (MS).

An FDA advisory committee will consider it this month...probably advise approval for patients with relapsing forms of MS.

Copaxone is given by injection...to suppress the immune response that leads to nerve damage. This reduces relapse rates...and might slow disability.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote